650 related articles for article (PubMed ID: 16799097)
1. Testosterone and doping control.
Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
[TBL] [Abstract][Full Text] [Related]
2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
3. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
[TBL] [Abstract][Full Text] [Related]
5. A steroidomic approach for biomarkers discovery in doping control.
Boccard J; Badoud F; Grata E; Ouertani S; Hanafi M; Mazerolles G; Lantéri P; Veuthey JL; Saugy M; Rudaz S
Forensic Sci Int; 2011 Dec; 213(1-3):85-94. PubMed ID: 21831550
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
[TBL] [Abstract][Full Text] [Related]
7. Detection of anabolic steroid abuse using a yeast transactivation system.
Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
[TBL] [Abstract][Full Text] [Related]
8. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport.
Becchi M; Aguilera R; Farizon Y; Flament MM; Casabianca H; James P
Rapid Commun Mass Spectrom; 1994 Apr; 8(4):304-8. PubMed ID: 8199357
[TBL] [Abstract][Full Text] [Related]
9. The application of carbon isotope ratio mass spectrometry to doping control.
Cawley AT; Flenker U
J Mass Spectrom; 2008 Jul; 43(7):854-64. PubMed ID: 18523972
[TBL] [Abstract][Full Text] [Related]
10. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
[TBL] [Abstract][Full Text] [Related]
11. Effects of propyphenazone and other non-steroidal anti-inflammatory agents on the synthetic and endogenous androgenic anabolic steroids urinary excretion and/or instrumental detection.
Mazzarino M; Braganò MC; Donati F; de la Torre X; Botrè F
Anal Chim Acta; 2010 Jan; 657(1):60-8. PubMed ID: 19951758
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of urinary excretion of androgens conjugated to cysteine in human pregnancy by mass spectrometry.
Fabregat A; Marcos J; Garrostas L; Segura J; Pozo OJ; Ventura R
J Steroid Biochem Mol Biol; 2014 Jan; 139():192-200. PubMed ID: 23410595
[TBL] [Abstract][Full Text] [Related]
14. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
[TBL] [Abstract][Full Text] [Related]
15. Endogenous steroid profiling in the athlete biological passport.
Sottas PE; Saugy M; Saudan C
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
[TBL] [Abstract][Full Text] [Related]
16. The potential of urinary androstdiene markers to identify 4-androstenediol (4-ADIOL) administration in athletes.
Cawley AT; Trout GJ; Kazlauskas R; George AV
Forensic Sci Int; 2011 May; 208(1-3):129-38. PubMed ID: 21177052
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
Van Eenoo P; Delbeke FT
J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
[TBL] [Abstract][Full Text] [Related]
18. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
19. Detecting the administration of endogenous anabolic androgenic steroids.
Ayotte C
Handb Exp Pharmacol; 2010; (195):77-98. PubMed ID: 20020361
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
